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ABSTRACT
Bone infection and metastatic spread in cases of
Buruli ulcer imply that Mycobacterium ulcerans is
able to survive and multiply at 37C. This study
investigated the survival at 37C of M. ulcerans
isolates from diverse geographical and clinical
sources. Although the viability of all isolates
decreased after a few days at 37C, viable
bacilli remained after 13 days at 37C in most
instances. African isolates of M. ulcerans were
more thermotolerant than isolates from temperate
regions. Isolates from skin and bone lesions of
the same patients showed no difference in
thermotolerance.
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Mycobacterium ulcerans, the causative agent of
Buruli ulcer (BU), grows optimally on mycobac-
teriological media at 30–32C [1]. M. ulcerans
classically infects skin and subcutaneous tissue,
where the pathogen encounters favourable
growth temperatures. However, metastatic
spread to distant skin sites or bone also occurs
[2–5], suggesting that M. ulcerans is able to sur-
vive and ⁄ or multiply at 37C. The present study
investigated the survival of M. ulcerans at 37C on
Lo¨wenstein–Jensen medium. The results may
have implications for: (i) a better understanding
of the clinical features of the disease, with bone
involvement resulting from metastatic spread;
(ii) the treatment of lesions with local heat; and
(iii) the epidemiology and transmission of the
disease in relation to survival of M. ulcerans in the
environment at high temperatures.
Seventeen isolates ofM. ulcerans from ten coun-
tries were initially studied. Tubes of Lo¨wenstein–
Jensen medium were inoculated with serial
dilutions of suspensions of bacteria and incubated
at 37C for 0, 3, 6, 9 or 24 h, and 2, 3, 6, 9 or 13 days,
and thereafter at 32C for 12 weeks. The number of
surviving bacilli was estimated by counting the
number of CFU. Inactivation curves were obtained
for each isolate by plotting CFU ⁄mL against
exposure time at 37C on a semi-logarithmic scale.
The slope of the inactivation curves was expressed
as decimal reduction time (D), measuring heat
resistance and the time needed to inactivate 90%
of the bacterial population at a given temperature.
A higher D value thus indicates a greater thermo-
tolerance [6,7].
Table 1 shows that a decrease in viability
occurred for all isolates after a few days at 37C,
but with large variations for individual isolates.
However, for all isolates except those from Japan,
China and French Guiana, viable bacilli were still
present after incubation for 13 days at 37C. The
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D values varied between 2.17 days for a Chinese
isolate, and 16.98 days for an isolate from Benin
(ITM 03-0216). This means that it takes 2.17 days
at 37C to reduce a bacterial population of
1000 CFU of the Chinese isolate to a population
of 100 CFU, while the same reduction would take
16.98 days for the isolate from Benin. Thus, the
Chinese isolate was much more sensitive to heat
inactivation at 37C than was the isolate from
Benin. The average D value of 9.03 days for
African isolates was higher than that for isolates
from other continents, but this was only signiﬁ-
cant when compared with isolates from non-
tropical countries in Australasia (p 0.027). In
non-tropical regions of Australia, China and
Japan, BU is complicated only rarely by the
osteomyelitis or multifocal forms that are seen
in Africa [4,5]. For this reason, African strains
might be expected to tolerate prolonged incuba-
tion at 37C. Schulze-Ro¨bbecke and Buchholtz [7]
found a D value of 2.33 days at 37C for a
Mycobacterium marinum strain from Philadelphia,
USA, which is comparable to the values obtained
in the present study for isolates from non-tropical
regions (average 3.33 days).
In a collection at this laboratory of 944 M.
ulcerans isolates from worldwide locations,
215 (22.8%) showed growth at 37C. Of these,
189 (87.9%) isolates yielded more colonies at 30C,
and only 23 (10.7%) showed the same growth at
37C and 30C. Interestingly, three (1.5%) African
isolates yielded more colonies at 37C than at
30C, which is in agreement with the higher
thermotolerance of African isolates at 37C that
was observed in the present study. African strains
of M. ulcerans also show genetic differences as
compared with strains from other continents
[8–12]. In addition, they are much more virulent
in a mouse model (F. Portaels et al., unpublished
data) and produce a different mycolactone [13].
Nineteen isolates from nine patients in Benin
with both bone and skin lesions were also
studied (Table 1). There was no difference in
thermotolerance among isolates from skin and
bone specimens (mean D values of 6.21 vs.
6.34 days, respectively). The disparity between
the thermotolerance of M. ulcerans to 37C on
Lo¨wenstein–Jensen medium and its resistance to
the same temperature in infected bone may be
explained by the differences between local con-
ditions in the bone and the bacteriological
growth medium.
In view of the efﬁcacy of heat treatment,
survival of M. ulcerans should also be tested at
temperatures >37C (e.g., 40C). Meyers et al. [14]
have demonstrated that a rigorously controlled
regimen of local heat therapy at 40C can be
curative for BU. Moreover, it was also found that
subsequent growth at 32C was retarded after
exposure of cultures of the bacteria to 37C for
1 day, and was completely inhibited after expo-
sure to 40C for 10 days. In a previous study, it
was observed that exposure to 41C for 1 day kills
>90% of the bacilli [15].
Table 1. Isolates of Mycobacterium ulcerans from different geographical or clinical origins showing their decimal reduction
times (D values) at 37C
Strain number Country of origin
D value
(days) Patient number Strain number Origin of specimen
D value
(days)
ITM 5142 Australia (Victoria); human tissue (ATCC 19423) 5.74 97-10 ITM 97-0952 Skin 4.28
ITM 95-1112 Australia (Victoria); human tissue 3.18 ITM 97-0684 Bone 7.27
ITM 8756 Japan; human tissue (ATCC 33728) 2.22 98-301 ITM 99-0826 Skin 10.60
ITM 98-0912 China; human tissue 2.17 ITM 99-0742 Bone 5.90
Average for non-tropical Australasia 3.33 ± 1.67 99-20 ITM 99-2654 Skin 3.81
ITM 94-1328 Malaysia; human tissue 7.81 ITM 99–1567 Bone 7.02
ITM 03-0524 Papua New Guinea; human tissue 3.37 99-86 ITM 99-1721 Skin 7.74
Average for tropical Australasia 5.59 ± 3.14 ITM 99-1722 Bone 6.88
ITM 5143 Mexico; human tissue 9.80 ITM 99-1723 Bone 4.47
ITM 842 Surinam; human tissue 3.12 99-226 ITM 99-2949 Skin 7.38
ITM 7922 French Guiana; human tissue 2.31 ITM 00-0040 Bone 4.15
Average for Latin America 5.08 ± 4.11 00-225 ITM 01-0566 Skin 5.18
ITM 95-1009 Togo; human tissue 5.04 ITM 01-0407 Bone 4.31
ITM 00-1441 Benin; aquatic insect 6.15 01-26 ITM 01-0498 Skin 3.73
ITM 96-0658 Angola; human tissue 6.05 ITM 01-0499 Bone 5.59
ITM 02-0279 Cameroon; human tissue 10.55 00-156 ITM 00-0946 Skin 7.48
ITM 03-0216 Benin; human tissue 16.98 ITM 00-0945 Skin 4.14
ITM 03-0221 Democratic Republic of Congo; human tissue 13.04 ITM 00-1034 Skin 7.70
ITM 94-0815 Coˆte d’Ivoire; human tissue 7.03 99-388 ITM 00-1714 Bone 11.48
ITM 01-1867 Ghana; human tissue 7.40 Average for bone 6.34 ± 2.27
Average for Africa 9.03 ± 4.16 Average for skin 6.21 ± 2.31
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Tolerance of M. ulcerans to moderately elevated
temperatures may have implications for the epi-
demiology of BU in tropical and non-tropical
countries. In southern Australia, which has a mild
temperate climate, it has been hypothesised that
M. ulcerans spreads in the environment through
aerosols arising from contaminated water, which
may, in turn, infect humans through contamina-
tion of skin lesions [16]. This seems plausible in
the temperate climate of southern Australia,
but in tropical areas, such as Africa, tempera-
tures away from water can be sufﬁciently
elevated (>40C) for M. ulcerans not to survive in
aerosols.
In conclusion, isolates obtained from skin and
bone lesions from the same patients show
no difference in thermotolerance, but African
isolates of M. ulcerans appear to be more thermo-
tolerant than isolates from temperate regions.
There was an increase in the D values, from
3.3 days for isolates from non-tropical Australasia
to 9.03 days for isolates from Africa. This obser-
vation could be linked to the fact that osteomy-
elitis and multifocal lesions occur in Africa, but
almost never occur in non-tropical Australasia.
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